'Shadowy' Co. Can't Ignore Eli Lilly's $20M High Court Appeal
A "shadowy non-practicing entity" will have to defend against Eli Lilly's U.S. Supreme Court appeal of a $20 million verdict over patent infringement claims concerning its Cialis drug after the high...To view the full article, register now.
Already a subscriber? Click here to view full article